Table 2 Pre-enrollment medication details of patients (n = 107).
Drugs | Number (percent) |
|---|---|
Drugs for Dyslipidemia | |
Atorvastatin | 29 (27.1) |
Rosuvastatin | 16 (15.0) |
Simvastatin | 6 (5.6) |
Fenofibrates | 11 (10.3) |
Statin plus fibrates | 27 (25.2) |
Statin plus Ezetamide | 7 (6.5) |
No treatment | 11 (10.3) |
Anti-diabetic drugs | |
Metformin | 94 (87.9) |
Sufonlyureas | 51 (47.7) |
Gliptins | 26 (24.3) |
Alpha glucosidase inhibitors | 19 (17.8) |
SGLT 2 inhibitors | 15 (14.0) |
Insulin | 15 (14.0) |
No treatment | 9 (8.4) |
Anti-hypertensives | |
ACEI/ARBs | 23 (21.5) |
CCB | 14 (13.1) |
Diuretics | 15 (14.0) |
Beta blockers | 12 (11.2) |
Others | 10 (9.3) |
